Peter Burgess - John Hancock Independent Trustee
| HPI Etf | USD 16.26 0.04 0.25% |
Mr. Peter S. Burgess is an Independent Trustee of the Fund. Mr. Burgess serve as a financial consultant, certified public accountant and a former partner in a major international public accounting firm, Mr. Burgess has experience in the auditing of financial services companies and mutual funds. He also has experience as a director of publicly traded operating companies.
| Age | 78 |
| Tenure | 12 years |
| Phone | 617-663-2430 |
| Web | https://www.jhinvestments.com/Fund/Overview.aspx?ProductType=ClosedEnd&FundID=34000&BackToFundTableType=Price&ClassCode=CE |
John Hancock Management Efficiency
The company has Return on Asset of 3.13 % which means that on every $100 spent on assets, it made $3.13 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of (6.92) %, meaning that it generated no profit with money invested by stockholders. John Hancock's management efficiency ratios could be used to measure how well John Hancock manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Thomas Kent | Tekla Healthcare Investors | 67 | |
| Roger Ko | Flaherty Crumrine Preferredome | 45 | |
| William Reardon | Tekla Life Sciences | 74 | |
| Christopher MBA | Tekla Healthcare Investors | N/A | |
| Curtis Holloway | Calamos Convertible And | 49 | |
| Linda Puchalski | Flaherty Crumrine Preferred | 63 | |
| Stephen Timbers | Calamos Convertible And | 70 | |
| Laura Woodward | Tekla Healthcare Investors | 51 | |
| William Reardon | Tekla World Healthcare | 74 | |
| John Neal | Calamos Convertible And | 68 | |
| Frank Gentile | Tekla Healthcare Investors | 62 | |
| Neil Bloom | Cohen And Steers | 44 | |
| Heather Kaden | Cohen And Steers | 40 | |
| Laurie Lodolo | Flaherty Crumrine Preferred | 56 | |
| Rakesh Jain | Tekla Life Sciences | 69 | |
| Stephen Timbers | Calamos Global Dynamic | 70 | |
| Elizabeth Nabel | Tekla Healthcare Investors | 67 | |
| Albert Laskaj | Cohen And Steers | 43 | |
| Lucinda Stebbins | Tekla World Healthcare | 73 | |
| David Tripple | Calamos Global Dynamic | 72 | |
| Michael Bonney | Tekla World Healthcare | 59 | |
Management Performance
| Return On Equity | -6.92 | ||||
| Return On Asset | 3.13 |
John Hancock Preferred Money Managers
| Warren Thomson, Non-Independent Trustee | ||
| Gregory Russo, Independent Trustee | ||
| Frances Rathke, Independent Trustee | ||
| Christopher Sechler, Secretary and Chief Legal Officer | ||
| William Cunningham, Independent Trustee | ||
| James Oates, Independent Chairman of the Board of Trustees | ||
| Craig Bromley, Non-Independent Trustee | ||
| James Boyle, Non-Independent Trustee | ||
| Deborah Jackson, Independent Trustee | ||
| Marianne Harrison, Trustee | ||
| Peter Burgess, Independent Trustee | ||
| Charles Bardelis, Independent Trustee | ||
| John Danello, Senior Vice President, Secretary and Chief Legal Officer | ||
| Francis Knox, Chief Compliance Officer | ||
| Steven Pruchansky, Independent Vice Chairman of the Board of Trustees | ||
| Theron Hoffman, Independent Trustee | ||
| Charles Rizzo, Chief Financial Officer | ||
| Grace Fey, Independent Trustee | ||
| Andrew Arnott, President, Trustee | ||
| Hassell McClellan, Independent Chairman of the Board of Trustees | ||
| Trevor Swanberg, Chief Compliance Officer | ||
| Salvatore Schiavone, Treasurer |
John Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is John Hancock a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.92 | ||||
| Return On Asset | 3.13 | ||||
| Profit Margin | (79.13) % | ||||
| Operating Margin | 86.43 % | ||||
| Current Valuation | 682.96 M | ||||
| Shares Outstanding | 26.3 M | ||||
| Shares Owned By Insiders | 0.05 % | ||||
| Shares Owned By Institutions | 12.77 % | ||||
| Number Of Shares Shorted | 8.16 K | ||||
| Price To Earning | 10.01 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards John Hancock in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, John Hancock's short interest history, or implied volatility extrapolated from John Hancock options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in John Hancock Preferred. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
The market value of John Hancock Preferred is measured differently than its book value, which is the value of John that is recorded on the company's balance sheet. Investors also form their own opinion of John Hancock's value that differs from its market value or its book value, called intrinsic value, which is John Hancock's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because John Hancock's market value can be influenced by many factors that don't directly affect John Hancock's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between John Hancock's value and its price as these two are different measures arrived at by different means. Investors typically determine if John Hancock is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, John Hancock's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.